Insight Molecular Diagnostics (IMDX) Construction in Progress (2019 - 2026)

Insight Molecular Diagnostics has disclosed Construction in Progress across 8 years of filings, most recently posting $471000.0 for Q1 2026.

• Construction in Progress for Q1 2026 came in at $471000.0, up 30.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $471000.0 (up 30.83% YoY), and the FY2025 annual result was $765000.0, up 125.0% from the prior year.
• Construction in Progress came in at $471000.0 for Q1 2026 at Insight Molecular Diagnostics, down from $765000.0 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $3.1 million in Q1 2022 to a low of $263000.0 in Q2 2025.
• The 5-year median for Construction in Progress is $685000.0 (2025), against an average of $997117.6.
• Across the five-year window, Construction in Progress jumped 730.52% in 2022 and tumbled 81.87% in 2023, its largest moves.
• Insight Molecular Diagnostics' Construction in Progress stood at $2.1 million in 2022, then tumbled by 66.07% to $726000.0 in 2023, then plunged by 53.17% to $340000.0 in 2024, then jumped by 125.0% to $765000.0 in 2025, then slumped by 38.43% to $471000.0 in 2026.
• The last three Construction in Progress figures came in at $471000.0 (Q1 2026), $765000.0 (Q4 2025), and $685000.0 (Q3 2025), per Business Quant data.